Why do bodybuilders specifically combine Testosterone Enanthate with HGH rather than running HGH alone?

HGH alone elevates IGF-1 but cannot fully activate androgen receptor-mediated anabolic pathways. Testosterone enanthate supplies the androgen tone that allows IGF-1-driven protein synthesis to convert into measurable lean mass. Clinical trials in adult men show GH plus testosterone produces significantly greater lean-mass accrual than GH monotherapy at matched cycle durations, as confirmed by DEXA body composition analysis.

What testosterone enanthate dose is typically used when stacking with Human Growth Hormone?

Most evidence-informed HGH combination protocols anchor testosterone enanthate at 200–400 mg per week. Lower weekly totals — around 200 mg — are favoured in body recomposition-focused runs where GH carries the anabolic load, while 300–400 mg weekly is used in lean-mass phases. Military Pharma Enanthate 300 at 1 ml per injection twice weekly delivers a clean 600 mg/week for more aggressive mass-building phases.

How long should a Testosterone Enanthate and HGH combined cycle run?

HGH requires extended administration — typically 16 to 24 weeks — before plateau-level IGF-1 benefits manifest. Testosterone enanthate should be run concurrently for the full GH cycle duration to maintain the androgen environment IGF-1 signalling depends on. Stopping testosterone early while continuing GH creates an androgenic deficit that blunts tissue remodelling outcomes and increases the risk of HGH-associated side effects such as fluid retention.

How should the 10 ml vial of Military Pharma Enanthate 300 be stored after first use?

After first puncture, store the vial upright at 15–25 °C away from direct light and heat sources. Do not refrigerate oil-based injectables, as cold temperatures increase viscosity and can cause the solution to cloud. Discard any unused solution 28 days after first draw; use a fresh sterile needle for every draw to maintain vial sterility throughout the multi-dose period.

Can Military Pharma Enanthate 300 be drawn with an insulin syringe for precise low-volume dosing?

At 300 mg/ml, a standard 1 ml insulin syringe graduated at 0.01 ml increments resolves doses in 3 mg steps — accurate enough for doses of 150 mg (0.50 ml) or 200 mg (0.67 ml). The 300 mg/ml concentration does increase solution viscosity slightly versus 250 mg/ml formats, so drawing through a larger-gauge needle first and then swapping to a finer injection needle is recommended for comfortable administration. (2) angle_used

Back in Stock

Military Pharma

Enanthate 300 300mg/ml 10ml Vial by Military Pharma

Name: Enanthate 300 300mg/ml 10ml Vial by Military Pharma
Brand: Military Pharma
SKU: INJ-TENA-MIL-300-019
Price: 32.00 EUR
Availability: InStock

Military Pharma Enanthate 300 is a 300 mg/ml oil-based injectable testosterone enanthate in a 10 ml multi-dose vial, purpose-formulated for sustained androgen support across long-duration HGH co-administration cycles. At 300 mg/ml, it delivers arithmetically clean dosing for the weekly testosterone windows that Growth Hormone stack protocols specifically require. Release testing covers concentration uniformity via HPLC and endotoxin control via LAL assay; every batch clears both acceptance criteria before dispatch.

€32.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Provides sustained androgen receptor activation that amplifies IGF-1-driven protein synthesis when co-administered with HGH
300 mg/ml concentration reduces injection volume burden during high-frequency GH sub-cutaneous injection schedules
Depot release profile supports stable trough serum testosterone across the extended 16–24 week timelines HGH protocols require
Enanthate ester enables twice-weekly injection scheduling that aligns cleanly with most HGH administration rhythms
10 ml multi-dose vial format simplifies bulk-phase planning for combined GH cycles without frequent reordering
Military Pharma batch-release testing covers HPLC content uniformity and LAL endotoxin validation before any vial ships
Oil-based formulation remains stable at room temperature, eliminating viscosity problems associated with refrigerated storage of injectable preparations

Phase	dosage	Note
HGH Recomposition Base	200 mg/week (0.67 ml twice weekly)	Anchors androgen tone while GH drives IGF-1-mediated fat loss and tissue remodelling; minimises estrogenic load during the longer HGH cycle duration
HGH Lean Mass Phase	300–400 mg/week (0.5–0.67 ml twice weekly)	Increases AR occupancy to maximise response to elevated IGF-1; suitable for users with bloodwork-confirmed testosterone tolerance and managed estradiol
Advanced Combined Protocol	400–600 mg/week (0.67–1.0 ml twice weekly)	Reserved for experienced users with full bloodwork monitoring; aromatase inhibitor titration required; do not increase dose without confirming estradiol remains below 40 pg/ml by LC-MS
Wind-Down (final 4 weeks of HGH cycle)	200 mg/week	Tapering testosterone toward cycle end while GH continues allows partial HPTA recovery signalling to begin before PCT; HGH may continue independently after testosterone cessation
Post-Cycle Therapy entry	Zero — cease testosterone	Allow 14 days after last Enanthate 300 injection before initiating SERM-based PCT; continue monitoring IGF-1 if GH post-cycle extension is planned

Key takeaways

Pair Enanthate 300 with HGH to activate both androgen receptor and IGF-1/mTORC1 anabolic pathways simultaneously.
Run testosterone enanthate for the full HGH cycle duration — 16 to 24 weeks — to sustain peak synergy.
Choose 200–400 mg weekly testosterone as the anchor dose in GH-inclusive body recomposition protocols.
Plan multi-vial supply upfront: one 10 ml vial covers approximately five weeks at 400 mg/week.
Verify IGF-1 and total testosterone blood panels at weeks 8 and 16 to calibrate dose adjustments.

Testosterone Enanthate as the Androgen Foundation of an HGH Stack

Military Pharma Enanthate 300 is a depot-injectable androgen delivering 300 mg of testosterone enanthate per millilitre, positioned specifically as the testosterone backbone for Human Growth Hormone combination programmes. HGH operates primarily through IGF-1 upregulation in the liver and peripheral tissues, but IGF-1-driven anabolic signalling requires adequate androgen receptor tone to translate fully into skeletal muscle hypertrophy — testosterone enanthate provides that receptor environment. Without a concurrent androgen, GH-induced IGF-1 elevation produces measurably attenuated lean-mass outcomes compared to protocols where testosterone is present, a relationship confirmed in published endocrinology literature using DEXA-based body composition assessment.

Why 300 mg/ml Works for HGH Co-Administration

The 300 mg/ml concentration occupies a practical dosing window for HGH stacks: a 0.67 ml draw yields exactly 200 mg, and a 1 ml draw yields 300 mg — both common weekly anchor doses in GH-inclusive protocols that prioritise body recomposition over sheer mass accumulation. Compared to 250 mg/ml formats, the same weekly testosterone dose requires roughly 17% less injection volume, which matters when GH itself is administered subcutaneously on a daily or twice-daily basis, making total injection burden a meaningful quality-of-life variable. Military Pharma engineers Enanthate 300 to stay injectable at room temperature without requiring elevated carrier-oil volumes that can contribute to post-injection discomfort during high-frequency injection schedules.

Physiological Synergies: What Testosterone and GH Do Together

Testosterone enanthate elevates androgen receptor density in skeletal muscle tissue, priming target cells for anabolic signals. Human Growth Hormone stimulates IGF-1 secretion, which in turn activates the mTORC1 pathway governing protein synthesis rate. The combination produces complementary, mechanistically distinct anabolic inputs: testosterone drives transcriptional upregulation of structural proteins via androgen response elements, while IGF-1/mTORC1 signalling accelerates ribosomal translational capacity. Clinical data from combined GH-plus-testosterone trials in hypogonadal men show lean-mass gains approximately 35–40% greater than testosterone alone at equivalent cycle lengths, measured by dual-energy X-ray absorptiometry (DEXA).

Cycle Length and PCT Alignment

HGH cycles typically run 16–24 weeks to allow IGF-1 levels to plateau and sustained tissue remodelling to occur. Testosterone enanthate's multi-day depot release aligns naturally with these extended timelines; twice-weekly injections maintain stable trough serum levels throughout the full GH run. Military Pharma's 10 ml vial supports approximately five weeks of standard 400 mg/week dosing per vial, making multi-vial planning straightforward for a 20-week combined programme.

Usage

Before beginning a combined Testosterone Enanthate + HGH programme, establish baseline bloodwork including total testosterone, free testosterone, estradiol (LC-MS preferred), IGF-1, and haematocrit to provide a reference for subsequent monitoring.
Draw the required Enanthate 300 volume using a large-bore drawing needle (18–21G); once the syringe is filled, swap to a 23–25G injection needle to minimise tissue trauma during administration.
Inject intramuscularly — glutes, quads, or delts — using a twice-weekly split (e.g. Monday and Thursday) to maintain even serum testosterone levels across the HGH cycle's extended timeline.
Administer HGH subcutaneously on your prescribed daily or twice-daily schedule, independent of testosterone injection days; the two compounds do not need to be injected simultaneously or in the same session.
At weeks 8 and 16 of your combined cycle, recheck total testosterone, estradiol, IGF-1, and haematocrit; adjust the Enanthate 300 weekly dose in increments of 50 mg based on bloodwork and clinical response rather than subjective feel alone.
After the final Enanthate 300 injection, wait approximately 14 days before starting SERM-based PCT to allow serum testosterone to fall; if extending HGH beyond testosterone cessation, continue monitoring IGF-1 quarterly and blood pressure monthly.

Warnings

Contraindications: Testosterone enanthate is contraindicated in individuals with androgen-sensitive prostate or breast carcinoma, untreated obstructive sleep apnoea, active polycythaemia, or known hypersensitivity to sesame or other carrier oils used in oil-based injectable formulations. Combined use with HGH is additionally contraindicated in active malignancy due to GH-mediated IGF-1 elevation.

Side Effects: Androgenic effects include accelerated androgenic alopecia, acne, and increased sebum production. Estrogenic conversion via aromatase can produce gynecomastia and fluid retention, particularly pronounced in extended HGH cycles where GH itself contributes to water retention. Polycythaemia risk increases with cycle duration; haematocrit readings above 52% require medical review. GH co-administration may additionally elevate fasting glucose via anti-insulin mechanisms.

Monitoring: Monitor estradiol, total testosterone, haematocrit, liver enzymes (ALT/AST), lipid panel, and IGF-1 at baseline, week 8, and week 16 of any combined cycle. Blood pressure should be checked monthly; GH-related fluid retention can elevate systolic values independent of testosterone dose. Adjust aromatase inhibitor dosing based on confirmed estradiol values, not symptoms alone.

PCT: Begin SERM-based PCT (Tamoxifen or Clomiphene) approximately 14 days after the final Enanthate 300 injection. A standard PCT runs 4–6 weeks. If HGH is continued post-testosterone, IGF-1 monitoring should continue throughout PCT to detect any interference with HPTA recovery signalling. Run bloodwork confirming LH, FSH, and total testosterone recovery before discontinuing PCT.

Frequently asked questions

Why do bodybuilders specifically combine Testosterone Enanthate with HGH rather than running HGH alone?: HGH alone elevates IGF-1 but cannot fully activate androgen receptor-mediated anabolic pathways. Testosterone enanthate supplies the androgen tone that allows IGF-1-driven protein synthesis to convert into measurable lean mass. Clinical trials in adult men show GH plus testosterone produces significantly greater lean-mass accrual than GH monotherapy at matched cycle durations, as confirmed by DEXA body composition analysis.
What testosterone enanthate dose is typically used when stacking with Human Growth Hormone?: Most evidence-informed HGH combination protocols anchor testosterone enanthate at 200–400 mg per week. Lower weekly totals — around 200 mg — are favoured in body recomposition-focused runs where GH carries the anabolic load, while 300–400 mg weekly is used in lean-mass phases. Military Pharma Enanthate 300 at 1 ml per injection twice weekly delivers a clean 600 mg/week for more aggressive mass-building phases.
How long should a Testosterone Enanthate and HGH combined cycle run?: HGH requires extended administration — typically 16 to 24 weeks — before plateau-level IGF-1 benefits manifest. Testosterone enanthate should be run concurrently for the full GH cycle duration to maintain the androgen environment IGF-1 signalling depends on. Stopping testosterone early while continuing GH creates an androgenic deficit that blunts tissue remodelling outcomes and increases the risk of HGH-associated side effects such as fluid retention.
How should the 10 ml vial of Military Pharma Enanthate 300 be stored after first use?: After first puncture, store the vial upright at 15–25 °C away from direct light and heat sources. Do not refrigerate oil-based injectables, as cold temperatures increase viscosity and can cause the solution to cloud. Discard any unused solution 28 days after first draw; use a fresh sterile needle for every draw to maintain vial sterility throughout the multi-dose period.
Can Military Pharma Enanthate 300 be drawn with an insulin syringe for precise low-volume dosing?: At 300 mg/ml, a standard 1 ml insulin syringe graduated at 0.01 ml increments resolves doses in 3 mg steps — accurate enough for doses of 150 mg (0.50 ml) or 200 mg (0.67 ml). The 300 mg/ml concentration does increase solution viscosity slightly versus 250 mg/ml formats, so drawing through a larger-gauge needle first and then swapping to a finer injection needle is recommended for comfortable administration. (2) angle_used

Manufacturer

Military Pharma's product portfolio demonstrates a deliberate ester-specific specialisation strategy: rather than producing broad-spectrum multi-compound blends, the brand concentrates its injectable hormone line on defined single-ester formulations — testosterone enanthate, testosterone propionate, and aqueous testosterone suspension among them — each engineered to distinct concentration targets suited to their pharmacokinetic class. Enanthate 300 reflects this approach directly: the 300 mg/ml specification was chosen to serve the volume-reduction demands of extended stack cycles, including GH co-administration programmes, where injection frequency and total volume per session are meaningful protocol variables. Quality control for each ester-specific preparation is conducted independently; HPLC quantification confirms active content against specification for every batch, and LAL endotoxin testing validates sterility parameters before release. Military Pharma's fill-finish infrastructure supports oil-based and aqueous preparations on segregated lines, preventing cross-formulation contamination risk inherent to multi-ester production environments.

Product details

Brand	Military Pharma
Active ingredient	testosterone enanthate
Also known as	Testosterone Enanthat, Test E, Testoviron, Delatestryl, Enanthate 300, Military Pharma Testosterone Enanthat
Strength	300 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TENA-MIL-300-019

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Testosterone Enanthate 250mg/ml 10x1ml Ampoules by Aburaihan Iran

Established Brand

Testosterone Enanthate 250mg/ml 10x1ml Ampullen by Aburaihan Iran

Aburaihan Iran Testosterone Enanthate 250mg/ml is a long-acting injectable androgen with a storied development arc stretching from mid-twentieth-century pharmaceutical research to its current status as one of the most clinically validated testosterone esters available. Each hermetically sealed 1ml glass ampoule delivers a precisely measured 250mg single dose, preserving sterility from the production line to the point of injection. Quality assurance at Aburaihan's Tehran facility is grounded in HPLC-verified potency testing, LAL endotoxin control, and GMP-compliant production protocols — standards embedded in every released lot.

€3.00

Enandrol 250mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

GMP Standard

Enandrol 250mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Enandrol by Balkan Pharmaceuticals is a pharmaceutical-grade Testosterone Enanthate solution, dosed at 250 mg per millilitre and presented in single-use 1 ml ampoules, manufactured to comply with EU Good Manufacturing Practice (GMP) regulations. Each ampoule is produced at Balkan Pharmaceuticals' GMP-certified facility in Moldova, where in-process and release testing covers potency, sterility, particulate matter, and bacterial endotoxins via LAL assay. Verified by HPLC-UV content analysis and subject to documented batch-release protocols: every unit reaching the customer carries a traceable quality record.

€38.00

Testoviron Depot 250mg/ml 1x1ml Ampoules by Schering

High Concentration

Testoviron Depot 250mg/ml 1x1ml Ampullen by Schering

Testoviron Depot by Bayer delivers 250mg/ml Testosterone Enanthate in a single-dose 1ml glass ampoule, purpose-built for integration into structured anabolic cycles where predictable plasma levels and precise dosing windows define protocol success. Its long-acting enanthate ester supports stable weekly or bi-weekly injection schedules, making it a natural fit for periodised bulking, recomposition, and TRT-bridging phases favoured by contemporary cycle planners. Quality assurance at Bayer is anchored by HPLC content-uniformity verification and endotoxin control via the LAL test — each ampoule released only after passing pre-defined acceptance thresholds.

€4.00

Season Highlight

Etho-Testosterone 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Etho-Testosterone by Beligas Pharmaceuticals is a single-ingredient injectable solution delivering Testosterone Enanthate at 300 mg per millilitre in a 10 ml multi-dose vial, purpose-built for athletes who structure their training year around distinct blast and cruise phases. The 300 mg/ml concentration allows precise volume-based dose adjustments across both the high-intensity blast period and the lower-dose cruise maintenance window, making phase transitions straightforward without switching products. Quality assurance covers full-batch release testing via HPLC for content uniformity and a validated LAL endotoxin screen; both acceptance criteria must be satisfied before a vial leaves the Beligas facility.

€38.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00